Gail Boudreaux, President and CEO at Elevance Health, bought ELV on Jul 17, 2026
Data as of Oct 16
- Traded
- Jul 17, 2026
- Disclosed
- Jul 17, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ELV since disclosure
+14.8%
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund
Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYGail Boudreaux President and CEOELV Elevance Health, Inc.$249Kdisclosed Jul 17 · filed the same day